Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human Cx30 ELISA Kit (AC3462)
Cat.#: ASET-2051
Specifications
Description Human Cx30 ELISA Kit allows for the in vitro quantitative determination of human Cx30 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-1590 Human SEMA4A ELISA Kit (AC3001) Quantitative inquiry ASET-1035 Mouse Adiponectin ELISA Kit (AC2446) Quantitative inquiry ASET-2151 Mouse Adenosine A1 Receptor ELISA Kit (AC3562) Quantitative inquiry ASET-2484 Mouse Nrg4 ELISA Kit (AC3895) Quantitative inquiry ASET-1870 Human Myelin Oligodendrocyte Glycoprotein ELISA Kit (AC3281) Quantitative inquiry ASET-1604 Rabbit IL-6 ELISA Kit (AC3015) Quantitative inquiry ASET-2383 Human VIP ELISA Kit (AC3794) Quantitative inquiry ASET-1170 Human LMOD1 ELISA Kit (AC2581) Quantitative inquiry ASET-2355 Mouse Kisspeptin ELISA Kit (AC3766) Quantitative inquiry ASET-1208 Mouse Adiponectin ELISA Kit (AC2619) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket